Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 16, 2016

Total Value: $514M (99.9% shares, 0.1% debt)

Holdings (17)

BIIB BIOGEN INC 18.5%

Value $94.97M Shares 310,000 Est. Cost $287.35 Unrealized 0.0%

ABBV ABBVIE INC. 18.2%

Value $93.6M Shares 1,580,000 Est. Cost $38.85 Unrealized -2.3%

— ARIAD PHARMACEUTICALS INC 15.6%

Value $80.31M Shares 12,850,000 Est. Cost $6.73 Unrealized —

— MEDICINES CO 11.4%

Value $58.51M Shares 1,567,000 Est. Cost $29.38 Unrealized —

DGX QUEST DIAGNOSTICS INC 8.0%

Value $40.91M Shares 575,000 Est. Cost $46.05 Unrealized +19.4%

PCRX PACIRA PHARMACEUTICALS INC 7.9%

Value $40.87M Shares 532,200 Est. Cost $59.93 Unrealized -5.5%

— INTRA CELLULAR THERAPIES INC 7.1%

Value $36.31M Shares 675,000 Est. Cost $27.96 Unrealized —

— AEGERION PHARMACEUTICALS INC 5.1%

Value $26.06M Shares 2,580,000 Est. Cost $22.50 Unrealized —

AMGN AMGEN INC 2.8%

Value $14.61M Shares 90,000 Est. Cost $104.63 Unrealized +11.3%

ESPR ESPERION THERAPEUTICS INC NE 1.9%

Value $9.972M Shares 448,000 Est. Cost $62.76 Unrealized -59.8%

— APRICUS BIOSCIENCES INC 1.3%

Value $6.459M Shares 6,524,505 Est. Cost $1.73 Unrealized —

— ARRAY BIOPHARMA INC 0.6%

Value $2.954M Shares 700,000 Est. Cost $4.22 Unrealized —

— AVEO PHARMACEUTICALS INC 0.6%

Value $2.915M Shares 2,313,759 Est. Cost $1.84 Unrealized —

— VIVUS INC 0.5%

Value $2.625M Shares 2,573,943 Est. Cost $9.08 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.3%

Value $1.399M Shares 31,000 Est. Cost $44.09 Unrealized -2.4%

— REPROS THERAPEUTICS INC 0.2%

Value $1.211M Shares 1,001,000 Est. Cost $16.90 Unrealized —

— TARGACEPT INC 0.1%

Value $680K Shares 680,399 Est. Cost $1.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BIIB	BIOGEN INC	310,000	$94.97M	18.5%	$287.35	0.0%	COM	09062X103
ABBV	ABBVIE INC.	1,580,000	$93.6M	18.2%	$38.85	-2.3%	COM	00287Y109
—	ARIAD PHARMACEUTICALS INC	12,850,000	$80.31M	15.6%	$6.73	—	COM	04033A100
—	MEDICINES CO	1,567,000	$58.51M	11.4%	$29.38	—	COM	584688105
DGX	QUEST DIAGNOSTICS INC	575,000	$40.91M	8.0%	$46.05	+19.4%	COM	74834L100
PCRX	PACIRA PHARMACEUTICALS INC	532,200	$40.87M	7.9%	$59.93	-5.5%	COM	695127100
—	INTRA CELLULAR THERAPIES INC	675,000	$36.31M	7.1%	$27.96	—	COM	46116X101
—	AEGERION PHARMACEUTICALS INC	2,580,000	$26.06M	5.1%	$22.50	—	COM	00767E102
AMGN	AMGEN INC	90,000	$14.61M	2.8%	$104.63	+11.3%	COM	031162100
ESPR	ESPERION THERAPEUTICS INC NE	448,000	$9.972M	1.9%	$62.76	-59.8%	COM	29664W105
—	APRICUS BIOSCIENCES INC	6,524,505	$6.459M	1.3%	$1.73	—	COM	03832V109
—	ARRAY BIOPHARMA INC	700,000	$2.954M	0.6%	$4.22	—	COM	04269X105
—	AVEO PHARMACEUTICALS INC	2,313,759	$2.915M	0.6%	$1.84	—	COM	053588109
—	VIVUS INC	2,573,943	$2.625M	0.5%	$9.08	—	COM	928551100
ANIP	ANI PHARMACEUTICALS INC	31,000	$1.399M	0.3%	$44.09	-2.4%	COM	00182C103
—	REPROS THERAPEUTICS INC	1,001,000	$1.211M	0.2%	$16.90	—	COM NEW	76028H209
—	TARGACEPT INC	680,399	$680K	0.1%	$1.00	—	NOTE 2/1	87611RAA6